The Senate has confirmed President Donald Trump’s pick to serve as White House drug czar.
Sara Carter Bailey, who will soon be officially sworn in as director of the Office of National Drug Control Policy (ONDCP) following a 52-48 confirmation vote on Tuesday, will play a central role in implementing the administration’s drug policy agenda. That includes everything from marijuana and psychedelics to harm reduction and overdose prevention.
The full Senate’s approval of Carter comes about three months after the Judiciary Committee advanced her nomination.
Carter has voiced support for medical cannabis, while stating that she doesn’t have a “problem” with legalization, even if she might not personally agree with the policy.
A former journalist known for her coverage of drug cartels, the incoming ONDCP director also previously advised senators that the administration was keeping “all options” on the table as it considered a marijuana rescheduling proposal, while describing cannabis reform as a “bipartisan issue.”
Despite her personal ambiguity on the rescheduling issue, Trump last month signed an executive order directing the attorney general to expeditiously complete the process of moving cannabis from Schedule I to Schedule III of the Controlled Substances Act (CSA).
Given the role of the ONDCP director
Read full article on Marijuana Moment
